Usana Health Sciences (USNA) Net Margin (2010 - 2026)

Usana Health Sciences (USNA) has reported Net Margin for 17 consecutive years, with 12.52% the latest figure, recorded in Q3 2026.

• On a quarterly basis, Net Margin fell 1695.0% year-over-year to 12.52% in Q3 2026; TTM through Jul 2026 was 3.2%, a 708.0% decrease from a year earlier, with the FY2026 full-year figure at 1.24%, down 368.0% from the prior year.
• Net Margin was 12.52% for Q3 2026 at Usana Health Sciences, down from 2.78% in the prior quarter.
• Over five years, Net Margin peaked at 8.23% in Q2 2022 and troughed at 12.52% in Q3 2026.
• A 5-year average of 3.94% and a median of 5.32% in 2023 frame the typical range for Net Margin.
• Across the five-year window, Net Margin jumped 197 bps in 2023 and sank 1695 bps in 2026, its largest moves.
• Over 5 years, Net Margin stood at 5.61% in 2022, then soared by 35 bps to 7.58% in 2023, then sank by 72 bps to 2.1% in 2024, then plunged by 249 bps to 3.12% in 2025, then tumbled by 302 bps to 12.52% in 2026.
• The last three Net Margin figures came in at 12.52% (Q3 2026), 2.78% (Q2 2026), and 0.71% (Q1 2026), per Business Quant data.